These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2081 related items for PubMed ID: 15893279

  • 1. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 2. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

  • 3. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J, Grancher K, Mandel F, Daum F.
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of chronic inflammatory bowel diseases].
    Lémann M.
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [Abstract] [Full Text] [Related]

  • 5. Managing the glucocorticoid dependent inflammatory bowel disease patient.
    Bonner GF.
    Semin Gastrointest Dis; 2001 Oct; 12(4):237-44. PubMed ID: 11726077
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
    Wahed M, Louis-Auguste JR, Baxter LM, Limdi JK, McCartney SA, Lindsay JO, Bloom SL.
    Aliment Pharmacol Ther; 2009 Sep 15; 30(6):614-20. PubMed ID: 19552632
    [Abstract] [Full Text] [Related]

  • 7. General principles of medical therapy of inflammatory bowel disease.
    Friedman S.
    Gastroenterol Clin North Am; 2004 Jun 15; 33(2):191-208, viii. PubMed ID: 15177534
    [Abstract] [Full Text] [Related]

  • 8. Medical management of patients with difficult-to-treat inflammatory bowel disease.
    van Hogezand RA.
    Neth J Med; 1994 Aug 15; 45(2):55-9. PubMed ID: 7936006
    [Abstract] [Full Text] [Related]

  • 9. [Treatment strategies for inflammatory bowel disease].
    Lémann M, Allez M.
    Rev Prat; 2005 May 15; 55(9):984-92. PubMed ID: 16052969
    [Abstract] [Full Text] [Related]

  • 10. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF.
    Am J Gastroenterol; 1998 Oct 15; 93(10):1860-6. PubMed ID: 9772045
    [Abstract] [Full Text] [Related]

  • 11. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T, Göke B, Sackmann M.
    Am J Gastroenterol; 2002 Aug 15; 97(8):2022-5. PubMed ID: 12190171
    [Abstract] [Full Text] [Related]

  • 12. Appropriate treatment for Crohn's disease: methodology and summary results of a multidisciplinary international expert panel approach--EPACT.
    Vader JP, Froehlich F, Juillerat P, Burnand B, Felley C, Gonvers JJ, Mottet C, Pittet V, Dubois RW, Wietlisbach V, Michetti P.
    Digestion; 2006 Aug 15; 73(4):237-48. PubMed ID: 16940727
    [Abstract] [Full Text] [Related]

  • 13. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA.
    Aliment Pharmacol Ther; 2004 Oct 15; 20 Suppl 4():102-5. PubMed ID: 15352904
    [Abstract] [Full Text] [Related]

  • 14. Inflammatory bowel disease: current therapeutic options.
    Domènech E.
    Digestion; 2006 Oct 15; 73 Suppl 1():67-76. PubMed ID: 16498254
    [Abstract] [Full Text] [Related]

  • 15. [Pharmacotherapy of inflammatory bowel disease].
    Jojić N.
    Acta Chir Iugosl; 2000 Oct 15; 47(1-2):51-5. PubMed ID: 10953366
    [Abstract] [Full Text] [Related]

  • 16. Optimizing therapy for inflammatory bowel disease.
    Robinson M.
    Am J Gastroenterol; 1997 Dec 15; 92(12 Suppl):12S-17S. PubMed ID: 9395347
    [Abstract] [Full Text] [Related]

  • 17. Immunosuppressive drugs in the treatment of inflammatory bowel disease.
    Aranda R, Horgan K.
    Semin Gastrointest Dis; 1998 Jan 15; 9(1):2-9. PubMed ID: 9547850
    [Abstract] [Full Text] [Related]

  • 18. Maintenance of medically induced remission of Crohn's disease.
    Gonvers JJ, Juillerat P, Mottet C, Pittet V, Felley C, Vader JP, Michetti P, Froehlich F.
    Digestion; 2007 Jan 15; 76(2):116-29. PubMed ID: 18239403
    [Abstract] [Full Text] [Related]

  • 19. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):829-39. PubMed ID: 15801918
    [Abstract] [Full Text] [Related]

  • 20. Inflammatory bowel disease: management issues during pregnancy.
    Ferrero S, Ragni N.
    Arch Gynecol Obstet; 2004 Sep 01; 270(2):79-85. PubMed ID: 12721680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 105.